These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 30937921

  • 1. Endothelin-A receptor in gastric cancer and enhanced antitumor activity of trastuzumab in combination with the endothelin-A receptor antagonist ZD4054.
    Shen W, Xi H, Li C, Bian S, Cheng H, Cui J, Wang N, Wei B, Huang X, Chen L.
    Ann N Y Acad Sci; 2019 Jul; 1448(1):30-41. PubMed ID: 30937921
    [Abstract] [Full Text] [Related]

  • 2. ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
    Smollich M, Götte M, Fischgräbe J, Macedo LF, Brodie A, Chen S, Radke I, Kiesel L, Wülfing P.
    Breast Cancer Res Treat; 2010 Sep; 123(2):345-57. PubMed ID: 19943105
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models.
    Yamashita-Kashima Y, Iijima S, Yorozu K, Furugaki K, Kurasawa M, Ohta M, Fujimoto-Ouchi K.
    Clin Cancer Res; 2011 Aug 01; 17(15):5060-70. PubMed ID: 21700765
    [Abstract] [Full Text] [Related]

  • 7. Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054.
    Growcott JW.
    Anticancer Drugs; 2009 Feb 01; 20(2):83-8. PubMed ID: 19065106
    [Abstract] [Full Text] [Related]

  • 8. ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer.
    Warren R, Liu G.
    Expert Opin Investig Drugs; 2008 Aug 01; 17(8):1237-45. PubMed ID: 18616419
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.
    Piro G, Carbone C, Cataldo I, Di Nicolantonio F, Giacopuzzi S, Aprile G, Simionato F, Boschi F, Zanotto M, Mina MM, Santoro R, Merz V, Sbarbati A, de Manzoni G, Scarpa A, Tortora G, Melisi D.
    Clin Cancer Res; 2016 Dec 15; 22(24):6164-6175. PubMed ID: 27267856
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
    James ND, Caty A, Borre M, Zonnenberg BA, Beuzeboc P, Morris T, Phung D, Dawson NA.
    Eur Urol; 2009 May 15; 55(5):1112-23. PubMed ID: 19042080
    [Abstract] [Full Text] [Related]

  • 13. Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer.
    Xiong J, Han S, Ding S, He J, Zhang H.
    Oncol Rep; 2018 Mar 15; 39(3):1396-1404. PubMed ID: 29328489
    [Abstract] [Full Text] [Related]

  • 14. Combined blockade of HER2 and VEGF exerts greater growth inhibition of HER2-overexpressing gastric cancer xenografts than individual blockade.
    Singh R, Kim WJ, Kim PH, Hong HJ.
    Exp Mol Med; 2013 Nov 01; 45(11):e52. PubMed ID: 24176949
    [Abstract] [Full Text] [Related]

  • 15. Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.
    Moody TW, Ramos-Alvarez I, Moreno P, Mantey SA, Ridnour L, Wink D, Jensen RT.
    Peptides; 2017 Apr 01; 90():90-99. PubMed ID: 28153500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Salvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in Vitro.
    Zhang Q, Wang S, Yu Y, Sun S, Zhang Y, Zhang Y, Yang W, Li S, Qiao Y.
    Int J Mol Sci; 2016 Aug 02; 17(8):. PubMed ID: 27490540
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model.
    Li Y, Liao Q, Li K, Zhong D, Weng X, Mi M.
    Mol Med Rep; 2012 Jun 02; 5(6):1391-5. PubMed ID: 22446894
    [Abstract] [Full Text] [Related]

  • 20. The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer.
    Wang Q, Zhang X, Shen E, Gao J, Cao F, Wang X, Li Y, Tian T, Wang J, Chen Z, Wang J, Shen L.
    Cancer Lett; 2016 Sep 28; 380(1):20-30. PubMed ID: 27317872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.